Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, (4), CD003728

Art Therapy for Schizophrenia or Schizophrenia-Like Illnesses

Affiliations
Review

Art Therapy for Schizophrenia or Schizophrenia-Like Illnesses

R Ruddy et al. Cochrane Database Syst Rev.

Abstract

Background: Many people with schizophrenia or schizophrenia-like illnesses continue to experience symptoms in spite of medication. In addition to medication, creative therapies, such as art therapy, may be helpful. Art therapy allows exploration of the patient's inner world in a non-threatening way through a therapeutic relationship and the use of art materials. It was mainly developed in adult psychiatric inpatient units and was designed for use with people for whom verbal psychotherapy would be impossible.

Objectives: To review the effects of art therapy as an adjunctive treatment for schizophrenia compared with standard care and other psychosocial interventions.

Search strategy: We updated the search of the Cochrane Schizophrenia Group's Register (February 2005), hand searched reference lists and 'Inscape' (the Journal of the British Association of Art Therapists), and contacted relevant authors.

Selection criteria: We included all randomised controlled trials that compared art therapy with standard care or other psychosocial interventions for schizophrenia.

Data collection and analysis: We reliably selected, quality assessed and extracted data from the studies. We excluded data where more than 50% of participants in any group were lost to follow up. For continuous outcomes we calculated a weighted mean difference and its 95% confidence interval. For binary outcomes we calculated a fixed effects risk ratio (RR), its 95% confidence interval (CI) and a number needed to treat (NNT).

Main results: The search identified 61 reports but only two studies (total n=137) met the inclusion criteria. Both compared art therapy plus standard care with standard care alone. More people completed the therapy if allocated to the art therapy group compared with standard care in the short (n=90, 1 RCT, RR 0.97 CI 0.41 to 2.29), medium (n=47, 1 RCT, RR 0.34 CI 0.15 to 0.80) and long term (n=47, 1 RCT, RR 0.96 CI 0.57 to 1.60). Data from one mental state measure (SANS) showed a small but significant difference favouring the art-therapy group (n=73, 1 RCT, WMD -2.3 CI -4.10 to -0.5). In the short term, a measure of social functioning (SFS) showed no clear difference between groups in endpoint scores (n=70, 1 RCT, WMD 7.20 CI -2.53 to 16.93) and quality of life, as measured by the PerQoL, did not indicate effects of art therapy (n=74, 1 RCT, WMD 0.1 CI -2.7 to 0.47).

Authors' conclusions: Randomised studies are possible in this field. Further evaluation of the use of art therapy for serious mental illnesses is needed as its benefits or harms remain unclear.

Update of

  • Art Therapy for Schizophrenia or Schizophrenia-Like Illnesses
    R Ruddy et al. Cochrane Database Syst Rev (2), CD003728. PMID 12804485. - Review
    Randomised studies have been proven to be possible in this field. The use of art therapy for serious mental illnesses should continue to be under evaluation as its benefi …

Similar articles

  • Art Therapy for Schizophrenia or Schizophrenia-Like Illnesses
    R Ruddy et al. Cochrane Database Syst Rev (2), CD003728. PMID 12804485. - Review
    Randomised studies have been proven to be possible in this field. The use of art therapy for serious mental illnesses should continue to be under evaluation as its benefi …
  • Drama Therapy for Schizophrenia or Schizophrenia-Like Illnesses
    RA Ruddy et al. Cochrane Database Syst Rev (1), CD005378. PMID 17253555. - Review
    Randomised studies are possible in this field. The use of drama therapy for schizophrenia and schizophrenia-like illnesses should continue to be under evaluation as its b …
  • Quetiapine for Schizophrenia
    M Srisurapanont et al. Cochrane Database Syst Rev (2), CD000967. PMID 15106155. - Review
    Quetiapine is effective for the treatment of schizophrenia, but it is not much different from first-generation antipsychotics and risperidone with respect to treatment wi …
  • Electroconvulsive Therapy for Treatment-Resistant Schizophrenia
    DJ Sinclair et al. Cochrane Database Syst Rev 3 (3), CD011847. PMID 30888709. - Meta-Analysis
    Moderate-quality evidence indicates that relative to standard care, ECT has a positive effect on medium-term clinical response for people with treatment-resistant schizop …
  • Early Intervention for Psychosis
    M Marshall et al. Cochrane Database Syst Rev (4), CD004718. PMID 17054213. - Review
    We identified insufficient trials to draw any definitive conclusions. The substantial international interest in early intervention offers an opportunity to make major pos …
See all similar articles

Cited by 20 PubMed Central articles

See all "Cited by" articles
Feedback